Multiple myeloma and second malignancies

Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):98-101. doi: 10.1016/j.clml.2013.11.008. Epub 2013 Nov 22.

Authors

Monika Engelhardt¹, Ralph Wäsch¹, Ola Landgren², Martina Kleber¹

Affiliations

¹ Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
² Multiple Myeloma Section, Metabolism Branch, National Cancer Institute, Bethesda, MD.

PMID: 24445186
DOI: 10.1016/j.clml.2013.11.008

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Female
Humans
Lenalidomide
Male
Multiple Myeloma / drug therapy*
Neoplasms, Second Primary / diagnosis*
Registries / statistics & numerical data*
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Thalidomide
Lenalidomide